FDA regulation of over-the-counter (OTC) drugs : overview and issues for Congress /

FDA regulation of over-the-counter (OTC) drugs : overview and issues for Congress /

Saved in:

Bibliographic Details
Main Author:	Bodie, Agata (Author)
Format:	Electronic eBook
Language:	English
Published:	[Washington, District of Columbia] : Congressional Research Service, [2021]
Series:	CRS report ; R46985. U.S. Congressional documents.
Subjects:	United States. > Food and Drug Administration > Rules and practice. Drugs, Nonprescription > Law and legislation > United States. Pharmaceutical industry > Law and legislation > United States. Legislative materials.
Online Access:	CONNECT

Similar Items

Regulation of over-the-counter (OTC) drugs /
by: Bodie, Agata
Published: (2016)

FDA's prescription to over-the-counter drug switch : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-eighth Congress, first session on the Food and Drug Administration's policies and procedures in switching drugs from prescription to over-the-counter status, June 6, 1983.
Published: (1983)

Modernizing FDA's regulation of over-the-counter drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session. September 13, 2017.
Published: (2018)

Modernizing FDA's regulation of over-the-counter drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session. September 13, 2017.
Published: (2018)

Regulation of over-the-counter drugs : hearing before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, first session, June 22, 1979.
Published: (1979)

Report of the Presiding Officer on proposed trade regulation rule : advertising for over-the-counter drugs : public record 215-51, 16 CFR part 450 /
by: Fitzpatrick, Roger J.
Published: (1978)

Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018 : report together with additional views (to accompany H.R. 5333) (including cost estimate of the Congressional Budget Office).
Published: (2018)

Over-the-counter drugs : harmless or hazardous? /
by: Sanberg, Paul
Published: (1986)

Emergency use authorization and FDA's related authorities /
by: Bodie, Agata
Published: (2018)

The legal regulation of sales of over-the-counter cold and allergy medication /
by: Feder, Jody
Published: (2006)

How FDA approves drugs and regulates their safety and effectiveness /
by: Bodie, Agata, et al.
Published: (2018)

FDA and drug prices : facilitating access to generic drugs /
by: Bodie, Agata
Published: (2019)

Drug shortages : causes, FDA authority, and policy options /
by: Bodie, Agata
Published: (2018)

FDA regulation of cosmetics and personal care products /
by: Sheikh, Hassan Z., et al.
Published: (2022)

Dietary Supplement and Nonprescription Drug Consumer Protection Act (P.L. 109-462) /
by: Porter, Donna Viola
Published: (2007)

Nonprescription drugs : considering a new class for behind-the-counter drugs /
Published: (2010)

Drug compounding, FDA has taken steps to implement compounding law, but some states and stakeholders reported challenges : report to Congressional Committees.
Published: (2016)

FDA regulation of cannabidiol (CBD) consumer products /
by: Bodie, Agata, et al.
Published: (2020)

FDA regulation of follow-on biologics.
Published: (2010)

Look alike drugs : hearing before the Subcommittee on Crime of the Committee on the Judiciary, House of Representatives, Ninety-seventh Congress, first session on look alike drugs, October 14, 1981.
Published: (1983)

FDA risk evaluation and mitigation strategies (REMS) : description and effect on generic drug development /
by: Bodie, Agata
Published: (2018)

Safety and efficacy of over-the-counter drug use by the elderly : hearing before the Subcommittee on Health and Long-Term Care of the Select Committee on Aging, House of Representatives, Ninety-eighth Congress, first session, July 21, 1983.
Published: (1983)

Safety and efficacy of over-the-counter drug use by the elderly : hearing before the Subcommittee on Health and Long-Term Care of the Select Committee on Aging, House of Representatives, Ninety-eighth Congress, first session, July 21, 1983.
Published: (1984)

FDA warning letters : trends and perspectives.
Published: (1999)

FDA warning letters : timeliness and effectiveness.
Published: (1999)

FDA regulation of cannabidiol (CBD) products /
by: Bodie, Agata, et al.
Published: (2019)

Tamper-resistant packaging for over-the-counter drugs : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-seventh Congress, second session, October 15, 1982.
Published: (1982)

Drug compounding : FDA authority and possible issues for Congress /
by: Bodie, Agata
Published: (2018)

How FDA approves drugs and regulates their safety and effectiveness.
Published: (2013)

Reinventing the regulation of drugs made from biotechnology /
Published: (1995)

FDA regulation of follow-on biologics [April 7, 2008] /
by: Johnson, Judith A. 1957-
Published: (2008)

FDA regulation of follow-on biologics [June 18, 2007] /
by: Johnson, Judith A. 1957-
Published: (2007)

FDA regulation of follow-on biologics [February 24, 2009] /
by: Johnson, Judith A. 1957-
Published: (2009)

FDA regulation of follow-on biologics [August 6, 2007] /
by: Johnson, Judith A. 1957-
Published: (2007)

FDA regulation of follow-on biologics [June 27, 2008] /
by: Johnson, Judith A. 1957-
Published: (2008)

Imitation Controlled Substances Act of 1983 : hearing before the Subcommittee on Alcoholism and Drug Abuse of the Committee on Labor and Human Resources, United States Senate, Ninety-eighth Congresses, first session, on S. 503, to make it unlawful to manufacture, distribute, or possess with intent to distribute, a drug which is an imitation of a controlled substance on a drug which purports to act like a controlled substance, July 14, 1983.
Published: (1983)

Cold medications : health care or hype? : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, second session, April 8, 1992.
Published: (1993)

FDA human medical product user fee programs /
by: Bodie, Agata, et al.
Published: (2021)

Symptoms in the pharmacy : a guide to the management of common illness /
by: Blenkinsopp, Alison
Published: (2009)

Reforming Federal drug regulation : a round table held on February 23, 1976, and sponsored by the Center for Health Policy Research of the American Enterprise Institute for Public Policy Research, Washington, D.C. /
Published: (1976)